the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Let’s talk about sex

OVER the years, there has been a huge debate over whether sex education should be taught in schools. Currently, many schools solely teach abstinence, or prefer to leave the issue of sex education to parents.

Child advocates claim that this goes against years of extensive research on the issue which has shown that the lack of comprehensive sexuality education (CSE) leaves youth at a disadvantage when it comes to their physical and emotional well-being.

They frequently cite the stand of the World Health Organisation, which states on its website that CSE “plays a central role in the preparation of young people for a safe, productive, fulfilling life in a world where HIV and AIDS, sexually transmitted infections (STIs), unintended pregnancies, gender-based violence (GBV) and gender inequality still pose serious risks to their well-being.”

This year, women’s groups have renewed their call for CSE to be made a mandatory part of the school syllabus to help equip the younger generation with the right knowledge about their sexual and reproductive health, as well as building healthy relationships with their peers and adults.

Sisters In Islam (SIS) communications officer Aleza Othman was quoted as saying that CSE should be made a standalone subject, instead of a component of physical education, religious or scientific subjects, while partner-director of KRYSS Network Angela M. Kuga Thas stated that it would help teach students how to better manage peer pressure around sex, as well as foster more respectful relationships between boys and girls.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings